Baillie Gifford & Co’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,691
Closed -$152K 292
2023
Q3
$152K Sell
15,691
-327
-2% -$5.11K ﹤0.01% 281
2023
Q2
$349K Hold
16,018
﹤0.01% 281
2023
Q1
$450K Hold
16,018
﹤0.01% 278
2022
Q4
$360K Hold
16,018
﹤0.01% 288
2022
Q3
$383K Sell
16,018
-17,771
-53% -$574K ﹤0.01% 286
2022
Q2
$983K Sell
33,789
-857,336
-96% -$38.3M ﹤0.01% 275
2022
Q1
$82.8M Buy
891,125
+1,075
+0.1% +$93.4K 0.06% 150
2021
Q4
$84.8M Buy
890,050
+10,835
+1% +$1.48M 0.05% 152
2021
Q3
$157M Buy
879,215
+32,973
+4% +$7.33M 0.08% 126
2021
Q2
$249M Buy
846,242
+188,029
+29% +$55.6M 0.12% 117
2021
Q1
$177M Buy
658,213
+500,457
+317% +$152M 0.1% 127
2020
Q4
$36.4M Buy
157,756
+56,529
+56% +$15.2M 0.02% 178
2020
Q3
$25.4M Buy
101,227
+29,367
+41% +$6.96M 0.02% 175
2020
Q2
$19.4M Buy
+71,860
New +$19.7M 0.01% 170

Other funds holding BNR